Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutrien
NTR
|
+$117M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$36.3M |
| 3 |
Becton Dickinson
BDX
|
+$30.5M |
| 4 |
Alibaba
BABA
|
+$29.1M |
| 5 |
NXP Semiconductors
NXPI
|
+$25.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$443M |
| 2 |
Microsoft
MSFT
|
+$315M |
| 3 |
Amazon
AMZN
|
+$275M |
| 4 |
Meta Platforms (Facebook)
META
|
+$191M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.01% |
| 2 | Healthcare | 14.49% |
| 3 | Consumer Discretionary | 11.53% |
| 4 | Industrials | 10.43% |
| 5 | Communication Services | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Supernus Pharmaceuticals
SUPN
$2.74B
| $4.05M | ﹤0.01% |
88,400
+2,000
| +2% | +$83.5K |
|
1177
Axos Financial
AX
$5.72B
| $4.04M | ﹤0.01% |
99,700
+2,200
| +2% | +$80.2K |
|
|
HZNP
1178
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.04M | ﹤0.01% |
284,456
+6,300
| +2% | +$93.1K |
|
1179
Box
BOX
$4.66B
| $4.04M | ﹤0.01% |
196,500
+25,400
| +15% | +$547K |
|
|
MIK
1180
DELISTED
Michaels Stores, Inc
MIK
| $4.04M | ﹤0.01% |
204,843
+4,500
| +2% | +$108K |
|
1181
Simpson Manufacturing
SSD
$8B
| $4.03M | ﹤0.01% |
70,000
+2,400
| +4% | +$139K |
|
1182
CoreCivic
CXW
$3.13B
| $4.02M | ﹤0.01% |
205,918
+6,700
| +3% | +$145K |
|
1183
Qualys
QLYS
$6.78B
| $4.02M | ﹤0.01% |
55,200
| – | – |
|
|
PSB
1184
DELISTED
PS Business Parks, Inc.
PSB
| $4.01M | ﹤0.01% |
35,508
+700
| +2% | +$80.6K |
|
1185
Liberty Latin America Class C
LILAK
$1.65B
| $4.01M | ﹤0.01% |
245,556
+5,491
| +2% | +$101K |
|
1186
SITE Centers
SITC
$158M
| $3.99M | ﹤0.01% |
422,509
+3,648
| +0.9% | +$36.7K |
|
1187
Old National Bancorp
ONB
$10.4B
| $3.99M | ﹤0.01% |
235,984
+5,200
| +2% | +$91.5K |
|
1188
PENN Entertainment
PENN
$2.53B
| $3.97M | ﹤0.01% |
151,100
+3,300
| +2% | +$95.3K |
|
1189
Merit Medical Systems
MMSI
$5.4B
| $3.96M | ﹤0.01% |
87,300
+1,900
| +2% | +$86K |
|
1190
Ultragenyx Pharmaceutical
RARE
$2.6B
| $3.96M | ﹤0.01% |
77,652
+7,700
| +11% | +$388K |
|
1191
KBR
KBR
$4.81B
| $3.94M | ﹤0.01% |
243,641
+3,700
| +2% | +$67.2K |
|
|
WFT
1192
DELISTED
Weatherford International plc
WFT
| $3.94M | ﹤0.01% |
1,722,500
+37,900
| +2% | +$121K |
|
1193
Bloomin' Brands
BLMN
$924M
| $3.94M | ﹤0.01% |
162,200
+3,100
| +2% | +$70.2K |
|
1194
STAG Industrial
STAG
$7.12B
| $3.93M | ﹤0.01% |
164,400
+7,300
| +5% | +$178K |
|
|
AXE
1195
DELISTED
Anixter International Inc
AXE
| $3.92M | ﹤0.01% |
51,800
| – | – |
|
1196
Empire State Realty Trust
ESRT
$836M
| $3.92M | ﹤0.01% |
233,500
+2,400
| +1% | +$43.4K |
|
1197
Match Group
MTCH
$8.56B
| $3.92M | ﹤0.01% |
88,100
+21,300
| +32% | +$824K |
|
|
ESGR
1198
DELISTED
Enstar Group
ESGR
| $3.91M | ﹤0.01% |
18,600
+500
| +3% | +$103K |
|
1199
Descartes Systems
DSGX
$6.62B
| $3.91M | ﹤0.01% |
136,900
+8,800
| +7% | +$245K |
|
1200
Rexford Industrial Realty
REXR
$8.12B
| $3.9M | ﹤0.01% |
135,616
+14,600
| +12% | +$413K |
|
Similar funds
Swiss National Bank's Q1 2018 Portfolio in Review
As of Q1 2018, Swiss National Bank held 2,520 positions worth $82B, down 11% from $92.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Swiss National Bank withdrew a net $9.58B in Q1 2018, closing 36 positions and reducing 634 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $66.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Nutrien worth $111M.
- Swiss National Bank's largest Q1 2018 buy was Nutrien: 2,341,052 shares worth $111M.
- Swiss National Bank added most to Worldpay, Inc. in Q1 2018, an estimated $36.3M increase.
- Swiss National Bank's biggest Q1 2018 reduction was Apple, cutting an estimated $443M.
- Swiss National Bank fully exited Potash Corp Of Saskatchewan in Q1 2018, selling an estimated $66.5M.
- Swiss National Bank's ten largest holdings make up 17% of its $82B portfolio in Q1 2018.
- Swiss National Bank opened 6 new positions and closed 36 in Q1 2018.
- Swiss National Bank's portfolio value fell 11% quarter-over-quarter to $82B.
Based on Swiss National Bank's 13F filing for Q1 2018, filed 4 May 2018.